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PREVENTING TYPE 2 DIABETES
NHS Diabetes Prevention Programme is vital but
criteria need reviewing
Nicola Guess lecturer
King’s College London, Franklin Wilkins Building, London SE1 9NH, UK
I agree with Barry and colleagues that we will not sustainably
reduce the incidence and prevalence of type 2 diabetes (T2D)
without major changes to our working and living environments.1
However, I fully support the principles of the NHS Diabetes
Prevention Programme for the following reasons.
1 The current T2D epidemic is largely due to obesity, and
the time lag between necessary changes to food policy, living
and working practices, and changes in obesity prevalence
will probably take at least 20 years.
2 At least three million people have T2D diagnosed in
England each year, so in the next 20 years around 60 million
will develop T2D in England alone.
3 Given the efficacy of the diabetes prevention trials, we
have a moral and financial imperative to provide these high
risk patients with the support and tools to prevent or delay
T2D for as long as possible.
Regarding the specifics of the NHS programme itself, current
inclusion criteria are based on HbA1c and fasting glucose. In
most diabetes prevention trials, inclusion criteria were IGT
(impaired glucose tolerance) with or without IFG (impaired
fasting glucose). It’s therefore worrying that the test most widely
used by UK GPs has such poor sensitivity for the main inclusion
criteria used in the original studies. Furthermore, emerging data
suggest that lifestyle approaches to prevent T2D are not (as)
effective in people with isolated IFG.
I hope that robust interim analysis is conducted before the
planned stepping up of recruitment so that, if necessary,
modification to the inclusion criteria of the programme can be
carried out.
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